Clinical Trials Directory

Trials / Completed

CompletedNCT06316128

EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs

Status
Completed
Phase
Study type
Observational
Enrollment
2,806 (actual)
Sponsor
Heart Care Foundation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This registry has the aim to assess the use of different antithrombotic therapies, including untested drug combinations, routinely used during the hospitalization phase, with their timing, route and dose of administration, in consecutive patients discharged with a diagnosis NSTEMI or STEMI in Italian Cardiac care Units (CCUs) during a four-week study period.

Detailed description

EYESHOT-2 is a prospective, multicenter, observational, nationwide survey of patients discharged with a diagnosis NSTEMI or STEMI admitted to Italian CCUs. The survey will be designed to include all consecutive patients, who met the eligibility criteria, admitted in hospitals with or without cardiac catheterization laboratories and cardiac surgery facilities during a period of 4 weeks.

Conditions

Timeline

Start date
2024-02-01
Primary completion
2024-02-29
Completion
2024-03-15
First posted
2024-03-18
Last updated
2026-01-02

Locations

189 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06316128. Inclusion in this directory is not an endorsement.

EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs (NCT06316128) · Clinical Trials Directory